Donald G. Robertson
Pfizer (United States)(US)
Publications by Year
Research Areas
Metabolomics and Mass Spectrometry Studies, Liver Disease Diagnosis and Treatment, Gut microbiota and health, Drug-Induced Hepatotoxicity and Protection, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project(2008)559 cited
- → Metabonomics in Toxicology: A Review(2005)538 cited
- → Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project(2003)385 cited
- → Metabonomics: Evaluation of Nuclear Magnetic Resonance (NMR) and Pattern Recognition Technology for Rapid in Vivo Screening of Liver and Kidney Toxicants(2000)255 cited
- → Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease(2014)230 cited
- → Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease(2013)185 cited